home All News open_in_new Full Article

Las ventas del medicamento para la obesidad que está estudiando Lilly superarán los 12.200 millones en 2031

Se trata de una terapia oral, lo que le permitirá ganar cuota de mercado, según las previsiones de la consultora GlobalData. Más información: Mounjaro (Lilly) desbancará a Keytruda (MSD) como el medicamento más vendido en el año 2030


today 10 h. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3976981037
Add Watch Country

arrow_drop_down